drugset / Trial / NCT01157104

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

NCT01157104 ↗

Phase 1 Completed 20 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to evaluate the potential for a pharmacokinetic (PK) drug-drug interaction between IDX320 and IDX184 and to assess the safety and tolerability when the two drugs are administered in combination in healthy participants.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject IDX184 Other / unclassified 100 mg Oral
Subject IDX320 Unknown 400 mg Oral